Immune characterization of breast cancer metastases: prognostic implications.

导出 OA

翻译打印收藏纠错

作者： Maria Vittoria,Dieci ^[1] ; Vassilena,Tsvetkova ^[2] ; Enrico,Orvieto ^[3] ; Federico,Piacentini ^[4] ; Guido,Ficarra ^[5] ; Gaia,Griguolo ^[6] ; Federica,Miglietta ^[3] ; Tommaso,Giarratano ^[7] ; Claudia,Omarini ^[3] ; Serena,Bonaguro ^[7] ; Rocco,Cappellesso ^[7] ; Camillo,Aliberti ^[8] ; Grazia,Vernaci ^[3] ; Carlo Alberto,Giorgi ^[9] ; Giovanni,Faggioni ^[10] ; Giulia,Tasca ^[3] ; Pierfranco,Conte ^[7] ; Valentina,Guarneri ^[7]

作者单位： Department of Surgery, Oncology and Gastroenterology, University of Padova, Via Gattamelata 64, 35128, Padova, Italy. mariavittoria.dieci@unipd.it. ^[1] Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Via Gattamelata 64, 35128, Padova, Italy. mariavittoria.dieci@unipd.it. ^[2] Department of Surgery, Oncology and Gastroenterology, University of Padova, Via Gattamelata 64, 35128, Padova, Italy. ^[3] Department of Pathology, Azienda Ospedaliera di Padova, Padova, Italy. ^[4] Department of Medical and Surgical Sciences of Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy. ^[5] Division of Pathology, University Hospital of Modena, Modena, Italy. ^[6] Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Via Gattamelata 64, 35128, Padova, Italy. ^[7] Department of Medical Oncology, University Hospital of Modena, Modena, Italy. ^[8] Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padova, Padova, Italy. ^[9] Radiology, Istituto Oncologico Veneto IRCCS, Padova, Italy. ^[10]

关键词 HER2 Metastatic breast cancer PD-L1 Triple negative Tumor-infiltrating lymphocytes